Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Humana Inc    HUM

HUMANA INC (HUM)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at USD 227.89 USD in weekly data.
  • Graphically speaking, the timing seems perfect for purchasing the stock close to the USD 228.1 support.
  • The stock, which is currently worth 2017 to 0.57 times its sales, is clearly overvalued in comparison with peers.
  • The company's attractive earnings multiples are brought to light by a P/E ratio at 13.31 for the current year.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The tendency within the weekly time frame is positive above the technical support level at 227.89 USD
Weaknesses
  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The group usually releases earnings worse than estimated.
  • The company is not the most generous with respect to shareholders' compensation.
Ratings chart
Sector Managed Healthcare - NEC
1st jan.Capitalisation (M$)Investor Rating
HUMANA INC14.42%33 352
UNITEDHEALTH GROUP31.15%202 944
ANTHEM INC53.60%56 700
AETNA INC39.67%56 481
CIGNA CORPORATION48.41%48 809
CENTENE CORP68.36%16 556
WELLCARE HEALTH PLANS, INC.44.44%8 815
MOLINA HEALTHCARE, INC.37.84%4 270
MAGELLAN HEALTH INC8.97%1 971
More Results
Financials ($)
Sales 2017 53 596 M
EBIT 2017 3 311 M
Net income 2017 2 593 M
Finance 2017 3 320 M
Yield 2017 0,55%
P/E ratio 2017 13,17
P/E ratio 2018 19,35
EV / Sales 2017 0,56x
EV / Sales 2018 0,53x
Capitalization 33 352 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart HUMANA INC
Duration : Period : Day
Humana Inc Technical Analysis Chart | HUM | US4448591028 | 4-Traders
Duration : Period : Week
Humana Inc Technical Analysis Chart | HUM | US4448591028 | 4-Traders